Latest News for: allosteric site

Edit

Domain Therapeutics Discloses DT-9046 as a Groundbreaking Oral Drug Candidate for Inflammatory Diseases

Pharmiweb 20 Mar 2025
... advancement in PAR2 modulation employing a differentiated mechanism of action, targeting an allosteric binding site to fine-tune GPCR function and boost efficacy against this complex target.
  • 1
×